The present invention discloses the identification, isolation and cloning of a gene encoding a novel cancer antigen NY ESO-1CAG-3 and peptides thereof derived from various open reading frames from the NY ESO-1 gene. The novel cancer antigen and peptides are recognized by cytotoxic T lymphocytes in an HLA restricted manner. The products of the gene are promising candidates for immunotherapeutic strategies for the prevention, treatment and diagnosis of patients with cancer.

 
Web www.patentalert.com

< Method and kit for the determination of analyte concentration in blood

< Preparation of iodixanol

> Tumor associated antigen peptides and use of same as anti-tumor vaccines

> Sublingual buccal effervescent

~ 00278